The basics of epithelial–mesenchymal transition (EMT): A study from a structure, dynamics, and functional perspective-Reference-Cited by-同舟云学术

The basics of epithelial–mesenchymal transition (EMT): A study from a structure, dynamics, and functional perspective

Published:2019-02-05 Issue:9 Volume:234 Page:14535-14555
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Das Vishal¹,Bhattacharya Sourya²,Chikkaputtaiah Channakeshavaiah¹,Hazra Saugata²,Pal Mintu¹^ORCID

Affiliation:

1. Biological Sciences and Technology Division (Biotechnology Group) CSIR‐North East Institute of Science and Technology, Academy of Scientific and Innovative Research Jorhat Assam India

2. Department of Biotechnology Centre for Nanotechnology, Indian Institute of Technology Roorkee (IITR) Roorkee Uttarakhand India

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.28160

Reference230 articles.

1. miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy

2. Development of the Proteasome Inhibitor Velcade™ (Bortezomib)

3. Prospective identification of tumorigenic breast cancer cells

4. Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers

5. Regulation of Rho GTPases by p120-catenin

Cited by 184 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obovatol inhibits proliferation, invasion and immune escape of hepatocellular carcinoma cells through modulating the JAK/STST3/PD-L1 pathway;International Immunopharmacology;2024-11

2. Regulation of TGF-β2-induced epithelial-mesenchymal transition and autophagy in lens epithelial cells by the miR-492/<i>NPM1</i> axis;Biomolecules and Biomedicine;2024-09-06

3. Targeting STAT3 signaling pathway by curcumin and its analogues for breast cancer: A narrative review;Animal Models and Experimental Medicine;2024-09-02

4. PF-06952229, a selective TGF-β-R1 inhibitor: preclinical development and a first-in-human, phase I, dose-escalation study in advanced solid tumors;ESMO Open;2024-09

5. CAB39 modulates epithelial–mesenchymal transition through NF‐κB signaling activation, enhancing invasion, and metastasis in bladder cancer;Environmental Toxicology;2024-08-22